Satoshi Watanabe

29PUBLICATIONS
94CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Solid tumoursMolecular targetsExercise physiologyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (29)

|Jun 19, 2026
Clinical Factors Associated With Non-Completion of Durvalumab Maintenance Therapy After Chemoradiotherapy in Patients With Locally Advanced Non-Small Cell Lung Cancer: A Single-Center Retrospective Study.

|Jun 17, 2026
Sarcomatoid Transformation of Pulmonary Mucinous Adenocarcinoma as a Mechanism of Immunotherapy Resistance.

|Mar 05, 2026
Nintedanib enhances the antitumor efficacy of pd-1 blockade, potentially through inhibition of myeloid-derived suppressor cells and cancer-associated fibroblasts.

Ryo Suzuki, Satoshi Watanabe, Kunihiro Shono

|Feb 26, 2026
Is Plasma Total Antioxidant Capacity Elevated in Professional Soccer Athletes?: A Cross-Sectional Study.

Tomoharu Mochizuki, Takashi Ushiki, Hikaru Kanome

|Nov 14, 2025
Investigation of non-completion factors for durvalumab maintenance therapy in locally advanced non-small cell lung cancer.

Masaaki Kotake, Yuki Sakai, Satoshi Watanabe

|Jul 10, 2025
Chemoimmunotherapy Outcomes and Prognostic Factors in Patients with Advanced, Low PD-L1-Expressing Non-Small Cell Lung Cancer.

Tae Hata, Tadaaki Yamada, Yasuhiro Goto

Pageof 5

Frequent Collaborators

6 joint publications

Toshiaki Kikuchi

4 joint publications

Tadaaki Yamada

4 joint publications

Akihiro Yoshimura

4 joint publications

Koichi Takayama